Prosecution Insights
Last updated: August 15, 2026
Application No. 18/839,084

Antioxidant Compositions

Non-Final OA §101§102§103
Filed
Aug 16, 2024
Priority
Feb 17, 2022 — EU 22020061.2 +1 more
Examiner
MI, QIUWEN
Art Unit
Tech Center
Assignee
The Boots Company PLC
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
1087 granted / 1590 resolved
+8.4% vs TC avg
Strong +50% interview lift
Without
With
+49.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
40 currently pending
Career history
1625
Total Applications
across all art units

Statute-Specific Performance

§101
10.1%
-29.9% vs TC avg
§103
44.2%
+4.2% vs TC avg
§102
22.4%
-17.6% vs TC avg
§112
18.8%
-21.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1590 resolved cases

Office Action

§101 §102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-12 are pending. Claims 1-12 are examined on the merits. Claim Rejections –35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-11 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. First, the claimed invention must be to one of the four statutory categories. 35 U.S.C. 101 defines the four categories of invention that Congress deemed to be the appropriate subject matter of a patent: processes, machines, manufactures and compositions of matter. The latter three categories define "things" or "products" while the first category defines "actions" (i.e., inventions that consist of a series of steps or acts to be performed). See 35 U.S.C. 100(b) ("The term ‘process’ means process, art, or method, and includes a new use of a known process, machine, manufacture, composition of matter, or material."). See MPEP § 2106.03 for detailed information on the four categories. Second, the claimed invention also must qualify as patent-eligible subject matter, i.e., the claim must not be directed to a judicial exception unless the claim as a whole includes additional limitations amounting to significantly more than the exception. The judicial exceptions (also called "judicially recognized exceptions" or simply "exceptions") are subject matter that the courts have found to be outside of, or exceptions to, the four statutory categories of invention, and are limited to abstract ideas, laws of nature and natural phenomena (including products of nature). Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 573 U.S. 208, 216, 110 USPQ2d 1976, 1980 (2014) (citing Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576, 589, 106 USPQ2d 1972, 1979 (2013). See MPEP § 2106.04 for detailed information on the judicial exceptions. Claim(s) 1-11 is/are directed to a cosmetic composition comprising the antioxidant agents: green tea extract, Quercus petraea fruit extract and ferulic acid. Analysis of the flowchart: Step 1, is the claim directed to a process, machine, manufacture or composition of matter? Yes. The claim is directed to a composition of matter. Step 2A. Prong one: Is the claim directed to a law of nature, a natural phenomenon (product of nature), or an abstract idea? Yes, the claims are directed to nature based components, green tea extract, Quercus petraea fruit extract, and rice bran extract is a rich natural source of ferulic aid, because there is no indication that extraction has caused the components of green tea, Quercus petraea fruit, and rice bran that comprise the claimed compositions to have any characteristics that are different from the naturally occurring components in green tea, Quercus petraea fruit, and rice bran. Step 2A. Prong two: Does the claims recite additional elements that amount to significantly more than the judicial exception? No. The claim(s) of 1-11 does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception. The additional antioxidant agent could read on vitamin E, which exists in nature as well. Regarding claims 1-2, and 11, since there is no absolute amounts of the active ingredients are claimed as compared to the whole composition, the claimed composition encompasses embodiments where the active ingredients are in such small amounts that none of them impart any characteristic or markedly different characteristic. Also, this is a product claim and since there are no claimed method steps, there are no additional elements that apply, rely on, or use the judicial exception in a manner that imposes a meaningful limit on the judicial exception themselves. Therefore, the claims do not recite something significantly more than a judicial exception and are thus deemed patent ineligible subject matter. Claims 3-10 require certain amounts of components being present in the composition. However, there is no indication that the amounts claimed in the compositions result in a markedly different characteristic for the composition as compared to the components that occur in the nature. Regarding claims 1-11, a cosmetic composition does not result in a markedly different characteristic because green tea, Quercus petraea fruit, and rice bran already known for topical application, thus have that same characteristic. Step 2B. If additional elements of the claim provide an inventive concept (Step 2B) (also called "significantly more" than the recited judicial exception). No, no non-nature based components were recited in the claims. For the reasons described above, the claimed compositions are not markedly different from their closest naturally occurring counterparts and thus are product of nature judicial exceptions. The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claims do not recite any additional elements beyond the claimed compositions themselves. Also, this is a product claim and since there are no claimed method steps, there are no additional elements that apply, rely on, or use the judicial exception in a manner that imposes a meaningful limit on the judicial exception themselves. Therefore, the claims do not recite something significantly more than a judicial exception and are thus deemed patent ineligible subject matter. Claim Rejections –35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 2, 11, and 12 are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by anonymous (Anonymous, Defining gel, pp. 1-5, 1/25/2022, see IDS filed by Applicant on 12/16/24). Anonymous teaches Defining gel (thus a cosmetic composition, thus for topical application, thus claim 11 is met, thus cosmetic treatment of skin, thus claim 12 is met) comprising Oryza sativa bran extract (thus a rich source of the claimed ferulic acid), Quercus petraea fruit extract (thus the claimed material), Camellia sinensis leaf extract (thus the claimed green tea extract), Rosmarinus officinalis leaf extract (thus additional antioxidant, thus claim 2 is met) (page 3, see whole document). Therefore, the reference is deemed to anticipate the instant claim above. Claim Rejections –35 USC § 103 The following is a quotation of 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained through the invention is not identically disclosed or described as set forth in section 102 of this title, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negatived by the manner in which the invention was made. Claims 1-12 are rejected under 35 U.S.C. 103(a) as being unpatentable over Anonymous as applied to claims 1, 2, 11, and 12 above. The teachings of Anonymous are set forth above and applied as before. The teachings of Anonymous do not specifically teach the claimed amount of each component in the composition. It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to vary the amount of each component according to the preference of the customer. Determining an appropriate amount of the components within the composition is deemed merely a matter of judicious selection and routine optimization which is well within the purview of the skilled artisan. From the teachings of the references, it is apparent that one of the ordinary skills in the art would have had a reasonable expectation of success in producing the claimed invention. Thus, the invention as a whole is prima facie obvious over the references, especially in the absence of evidence to the contrary. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to QIUWEN MI whose telephone number is (571)272-5984. The examiner can normally be reached on Monday-Friday 9:00 am to 5:00 pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anand Desai can be reached on 571-272-0947. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Qiuwen Mi/ Primary Examiner, Art Unit 1655
Read full office action

Prosecution Timeline

Aug 16, 2024
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703836
MIXTURE OF COMPOUNDS WITH HIGH MOLECULAR WEIGHTS, OBTAINED FROM SUGAR CANE WAX (SACCHARUM OFFICINARUM L.)
2y 7m to grant Granted Aug 11, 2026
Patent 12696897
CRYOPRESERVING MACROPHAGES
3y 8m to grant Granted Aug 04, 2026
Patent 12697363
COMPOSITION FOR INHIBITING DIABETES MELLITUS AND METHOD OF MANUFACTURING THE SAME
3y 0m to grant Granted Aug 04, 2026
Patent 12691153
METHOD FOR IMPROVING BONE HEALTH BY USING MANGOSTEEN SHELL EXTRACT
2y 2m to grant Granted Jul 28, 2026
Patent 12678514
ALGAE-BASED MICROROBOT FOR DRUG DELIVERY
2y 3m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+49.6%)
2y 6m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1590 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month